• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物纳米颗粒作为药物载体应用的最新进展

Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.

作者信息

Moritz Michał, Geszke-Moritz Małgorzata

机构信息

Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.

NanoBioMedical Centre, Adam Mickiewicz University, Poznań, Poland.

出版信息

Adv Clin Exp Med. 2015 Sep-Oct;24(5):749-58. doi: 10.17219/acem/31802.

DOI:10.17219/acem/31802
PMID:26768624
Abstract

Nanotechnology is an interdisciplinary field of science offering interesting solutions for many branches of human life. Nanomaterials, defined as structures with at least one dimension below 100 nm, are the focus of increasing research attention as versatile tools for nanomedicine. Among the various nanostructures recently described in the literature, polymeric nanoparticles, characterized by satisfying biocompatibility, have aroused great interest as the carriers for various biologically active substances such as drugs, proteins and nucleic acids. These nanoparticles have already been reported as efficient vehicles for therapeutic agents in many disease entities. They can be delivered to the body via different administration routes. This review addresses recent advances in the usage of polymeric nanoparticles as drug carriers described in the years 2013 and 2014. The advantages of polymeric nanocarriers for medical application are highlighted, including their low toxicity, evaluated in vitro and in vivo. Moreover, the classification of polymeric nanoparticles is presented as well as various protocols of their synthesis.

摘要

纳米技术是一个跨学科的科学领域,为人类生活的许多分支提供了有趣的解决方案。纳米材料被定义为至少有一个维度低于100纳米的结构,作为纳米医学的通用工具,正日益成为研究关注的焦点。在最近文献中描述的各种纳米结构中,具有良好生物相容性的聚合物纳米颗粒作为药物、蛋白质和核酸等各种生物活性物质的载体引起了极大的兴趣。这些纳米颗粒已被报道为许多疾病实体中治疗剂的有效载体。它们可以通过不同的给药途径递送至体内。本综述阐述了2013年和2014年所描述的聚合物纳米颗粒作为药物载体应用的最新进展。强调了聚合物纳米载体在医学应用中的优势,包括其在体外和体内评估的低毒性。此外,还介绍了聚合物纳米颗粒的分类及其各种合成方案。

相似文献

1
Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.聚合物纳米颗粒作为药物载体应用的最新进展
Adv Clin Exp Med. 2015 Sep-Oct;24(5):749-58. doi: 10.17219/acem/31802.
2
Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.纳米颗粒和纳米给药系统的药物研发和监管考虑因素。
J Pharm Sci. 2013 Nov;102(11):3867-82. doi: 10.1002/jps.23691. Epub 2013 Aug 23.
3
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.聚合物颗粒技术用于口服药物传递和靶向给药:病理生理学视角。
Nanomedicine. 2012 Sep;8 Suppl 1:S5-20. doi: 10.1016/j.nano.2012.07.005. Epub 2012 Jul 27.
4
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
5
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.纳米包封 I. 载药聚合物纳米颗粒的制备方法。
Nanomedicine. 2006 Mar;2(1):8-21. doi: 10.1016/j.nano.2005.12.003.
6
Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.纳米技术在治疗学中的应用:聚焦于纳米粒子作为药物传递系统。
Nanomedicine (Lond). 2012 Aug;7(8):1253-71. doi: 10.2217/nnm.12.87.
7
Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.纳米医学中的无机中空纳米颗粒和纳米管 第1部分. 药物/基因递送应用
Drug Discov Today. 2007 Aug;12(15-16):650-6. doi: 10.1016/j.drudis.2007.06.002. Epub 2007 Jul 31.
8
Role of nanotechnology in developing new therapies for diseases of the nervous system.纳米技术在开发神经系统疾病新疗法中的作用。
Nanomedicine (Lond). 2006 Jun;1(1):9-12. doi: 10.2217/17435889.1.1.9.
9
Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.微流控和芯片实验室制备路线用于制备有机纳米粒子和用于纳米医学应用的囊泡系统。
Adv Drug Deliv Rev. 2013 Nov;65(11-12):1496-532. doi: 10.1016/j.addr.2013.08.002. Epub 2013 Aug 8.
10
Stimuli-responsive polymeric nanoparticles for nanomedicine.用于纳米医学的刺激响应性聚合物纳米颗粒。
ChemMedChem. 2015 Jan;10(1):24-38. doi: 10.1002/cmdc.201402290. Epub 2014 Oct 16.

引用本文的文献

1
Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.多功能 PLGA 纳米载体在三阴性乳腺癌治疗中的最新进展。
AAPS PharmSciTech. 2023 Dec 14;24(8):258. doi: 10.1208/s12249-023-02712-7.
2
Role of Organic and Inorganic Nanoparticles in the Drug Delivery System for Hypertension Treatment: A Systematic Review.有机和无机纳米颗粒在高血压治疗药物传递系统中的作用:系统评价。
Curr Cardiol Rev. 2022;18(1):e110621194025. doi: 10.2174/1573403X17666210611115823.
3
Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect.
负载阿奇霉素的羟氯喹聚合物纳米颗粒和纳米胶束增强抗SARS-CoV-2效果。
J Nanostructure Chem. 2023;13(2):263-281. doi: 10.1007/s40097-022-00476-3. Epub 2022 Feb 26.
4
Current applications and prospects of nanoparticles for antifungal drug delivery.纳米颗粒用于抗真菌药物递送的当前应用与前景
EXCLI J. 2021 Mar 8;20:562-584. doi: 10.17179/excli2020-3068. eCollection 2021.
5
A Methodological Safe-by-Design Approach for the Development of Nanomedicines.一种用于纳米药物开发的设计安全方法学途径。
Front Bioeng Biotechnol. 2020 Apr 2;8:258. doi: 10.3389/fbioe.2020.00258. eCollection 2020.
6
Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.用于药物递送的聚合物纳米生物材料的风险评估:到目前为止我们能从文献中学到什么。
Front Bioeng Biotechnol. 2019 Oct 23;7:261. doi: 10.3389/fbioe.2019.00261. eCollection 2019.
7
Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles.通过形成固体药物纳米颗粒增强沙奎那韦的吸收和蓄积。
BMC Pharmacol Toxicol. 2018 Dec 4;19(1):79. doi: 10.1186/s40360-018-0275-5.
8
Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.载胆固醇油酸酯的阳离子固体脂质纳米粒作为高效基因沉默治疗的载体。
Int J Nanomedicine. 2018 May 30;13:3223-3233. doi: 10.2147/IJN.S158884. eCollection 2018.
9
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.全身真菌感染的抗真菌治疗与纳米生物技术时代:提高疗效、改善生物分布及降低毒性
Front Microbiol. 2017 Mar 7;8:336. doi: 10.3389/fmicb.2017.00336. eCollection 2017.